|
Video: What is a Stock Split?
|
|
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Co. has developed its Targeted Alpha Therapies, or TAT, platform together with its proprietary Fast-Clear linker technology to enable them to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Co. serves health care sectors in Canada. According to our FUSN split history records, Fusion Pharmaceuticals has had 1 split. | |
|
Fusion Pharmaceuticals (FUSN) has 1 split in our FUSN split history database. The split for FUSN took place on April 16, 1999. This was a 1 for 10
reverse split, meaning for each 10
shares of FUSN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Fusion Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the FUSN split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Fusion Pharmaceuticals shares, starting with a $10,000 purchase of FUSN, presented on a split-history-adjusted basis factoring in the complete FUSN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/29/2020 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$17.78 |
|
End price/share: |
$21.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
19.91% |
|
Average Annual Total Return: |
4.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,989.36 |
|
Years: |
3.75 |
|
|
|
Date |
Ratio |
04/16/1999 | 1 for 10
|
|
|